Company profilePharmaceutical#257 of 1,318 in Pakistan✓ No DRAP alerts

ADVANCED PHARMACEUTICALS

Pharmaceutical company · 71 brands · 66 molecules

71 registered products 41 pharmaceutical brands 66 distinct molecules 0 DRAP alerts

Company overview

71
registered products
41
pharmaceutical brands
66
distinct molecules
0
therapeutic classes
0
DRAP alerts

ADVANCED PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 71 product registrations across 66 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by ADVANCED

29 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

29
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202529

Top molecules by brand count

Cefixime5 brands
Cephalexin5 brands
Ceftazidime4 brands
Cefotaxime4 brands
Azithromycin3 brands
Levofloxacin3 brands
Piroxicam-Beta-Cyclodextrin2 brands

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official62 products · Rs 102.56 – Rs 845.83
Median across source: Rs 278.03

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 127 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtesunateAscorbic Acid
GETZ PHARMA PAKISTAN (PVT) LTD. holds 264 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
SEMOS PHARMACEUTICALS (PVT) LTD. holds 46 molecules not in this portfolio
AmodiaquineAmodiaquine 150MgArtesunateAscorbic AcidBisacodylBuprenorphine

Get the full profile for ADVANCED

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.